Box 2.
Access group | |||
---|---|---|---|
Medicine | ATC code# | Medicine | ATC code# |
Beta-lactam medicines | Other antibacterials | ||
Amoxicillin | J01CA04 | Amikacin | J01GB06 |
Amoxicillin + clavulanic acid | J01CR02 | Azithromycin∗ | |
Ampicillin | J01CA01 | Chloramphenicol | J01BA01 |
Benzathine benzylpenicillin | J01CE08 | Ciprofloxacin∗ | |
Benzylpenicillin | J01CE01 | Clarithromycin∗ | |
Cefalexin | J01DB01 | Clindamycin | J01FF01 |
Cefazolin | J01DB04 | Doxycycline | J01AA02 |
Cefixime∗ | Gentamicin | J01GB03 | |
Cefotaxime∗ | Metronidazole | J01XD01, P01AB01 | |
Ceftriaxone∗ | Nitrofurantoin | J01XE01 | |
Cloxacillin | J01CF02 | Spectinomycin | J01XX04 |
Phenoxymethylpenicillin | J01CE02 | Sulfamethoxazole + trimethoprim | J01EE01 |
Piperacillin + tazobactam∗ | Vancomycin (oral and parenteral)∗ | ||
Procaine benzylpenicillin | J01CE09 | ||
Watch group | |||
Medicine | ATC code | ||
Quinolones and fluoroquinolones e.g., ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin | J01MA, J01MB | ||
Third-generation cephalosporins (with or without beta-lactamase inhibitor) e.g., cefixime, ceftriaxone, cefotaxime, ceftazidime | J01DD | ||
Macrolides e.g., azithromycin, clarithromycin, erythromycin | J01FA | ||
Glycopeptides e.g., teicoplanin, vancomycin | J01XA, A07AA09 | ||
Antipseudomonal penicillins with beta-lactamase inhibitor e.g., piperacillin + tazobactam | J01CR03, J01CR05 | ||
Carbapenems e.g., meropenem, imipenem + cilastatin | J01DH | ||
Penems e.g., faropenem | J01DI03 | ||
Reserve group | |||
Medicine | ATC code | ||
Aztreonam | J01DF01 | ||
Fourth-generation cephalosporins e.g., cefepime | J01DE | ||
Fifth-generation cephalosporins e.g., ceftaroline | J01DI02, J01DI01, J01DI54 | ||
Fosfomycin IV | J01XX01 (Only parenteral) | ||
Oxazolidinone e.g., linezolid | J01XX08, J01XX11 | ||
Polymyxins e.g., polymyxin B, colistin | J01XB, A07AA10, A07AA05 | ||
Tigecycline | J01AA12 | ||
Daptomycin | J01XX09 | ||
∗Watch group antibiotics included in the EML/EMLc only for specific, limited indications; #ATC codes shown for medicines in the core access list – i.e., no overlap with Watch group antibiotics.
Medicines not specifically identified in the groups described form an “ungrouped” medicines category.